おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ABclonal
company
About
ABclonal is a biotechnology company that is a supplier of global antibody and molecular enzyme reagents.
- 251 - 500
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- ¥1.20B
- Industries
- Biometrics,Biopharma,Biotechnology
- Founded date
- Jan 1, 2011
- Number Of Employee
- 251 - 500
- Operating Status
- Active
ABclonal Technology is a rapidly growing life science research and diagnostic reagents provider. With scientists from world-class universities, the company thrives on improving the quality of life science research by providing high-quality antibodies, proteins, ELISA kits, NGS library preparation kits and molecular enzymes.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
¥1.20B $93M
ABclonal has raised a total of
¥1.20B $93M
in funding over 2 rounds. Their latest funding was raised on
Dec 8, 2021 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 8, 2021 | Series D | ¥1.20B | 2 | — | — | Detail |
| Feb 22, 2021 | Series C | $93M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
4
ABclonal is funded by 4 investors.
Taikang Touzi
and Zhengxingu Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Series D |
|
|
— | Series C |
Sigma Square Capital
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
